What is the incidence of atonic postpartum hemorrhage (PPH) in the general population and in high-risk patients with a history of previous PPH, multiple gestations, or prolonged labor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Atonic Postpartum Hemorrhage

Uterine atony accounts for more than 75% of all postpartum hemorrhage cases and is the leading cause of early PPH, which affects 2-3% of all deliveries in developed countries. 1

Overall PPH Incidence

  • Postpartum hemorrhage complicates approximately 2.9% of all deliveries, with uterine atony responsible for 79% of these cases 2
  • The incidence of PPH varies across populations from 1.2% to 12.5% depending on definitions and healthcare settings 3
  • Severe PPH (defined as PPH requiring transfusion, hysterectomy, or surgical repair) occurs in 3.0 per 1000 deliveries 4
  • In France, severe PPH (blood loss >1000 mL) occurs during 2% of deliveries 1

Temporal Trends

  • The overall rate of PPH increased 27.5% from 1995 to 2004, primarily driven by increases in uterine atony 2
  • Severe PPH rates doubled from 1.9 to 4.2 per 1000 deliveries between 1999 and 2008, with increases in both atonic and non-atonic PPH 4
  • This rising incidence is not explained by changes in traditional risk factors, which account for only 5.6% of the increase 4

High-Risk Populations for Atonic PPH

History of previous severe PPH confers the highest risk, with an 8.97-fold increased odds of recurrence (95% CI: 5.25-15.33) 5

Specific Risk Factors for Atonic PPH:

  • Multiple gestation: 2.8-fold increased risk (95% CI: 2.6-3.0) 2
  • Prolonged labor and chorioamnionitis: 2.9-fold increased risk (95% CI: 2.5-3.4) 2
  • Maternal age extremes (<20 or ≥40 years): 1.5-fold increased risk 2
  • Cesarean delivery: 1.4-fold increased risk (95% CI: 1.3-1.5) 4
  • Polyhydramnios, retained placenta, and antepartum hemorrhage are independent risk factors 2

Critical Clinical Context

The majority (61.2%) of women who develop severe atonic PPH requiring transfusion have no identifiable risk factors beyond maternal age and mode of delivery 2. This underscores that all deliveries require preparedness for managing uterine atony, regardless of apparent risk profile.

Mortality Impact:

  • PPH is associated with 19.1% of all in-hospital deaths after delivery 2
  • Between 2013-2015, maternal mortality from obstetrical hemorrhage represented 8.4% of peripartum deaths 1
  • In developed countries, mortality from PPH approximates 0.03% 1

Related Questions

What is the most common cause of 1000 cc of vaginal bleeding after an uneventful vaginal delivery with a firm uterus?
What puts a pregnant female with a history of postpartum hemorrhage (PPH) in her previous pregnancy at high risk of PPH in her current singleton pregnancy?
What is the management for a postpartum hemorrhage with an estimated blood loss of 450 ml during vaginal delivery?
What are the causes of postpartum hemorrhage (PPH)?
What are the key management strategies for High Acuity Low Occurrence (HALO) events in Obstetrics and Gynecology, including postpartum hemorrhage, severe preeclampsia, and amniotic fluid embolism?
What should a patient with a history of allergies do if they are unsure if they took their scheduled dose of amoxicillin?
What is the appropriate workup and treatment for a patient presenting with hypocalcemia, including those with a history of thyroid or parathyroid surgery, or those taking medications such as phenytoin (antiepileptic) or phenobarbital (barbiturate)?
What is the best management approach for a patient with a history of cerebrovascular accident (CVA) and Chronic Kidney Disease (CKD) stage 3b who also has hyperkalemia?
What is the best course of management for a middle-aged adult patient with a history of cardiovascular disease, atrial fibrillation, and diabetes mellitus, presenting with a vesicular rash on the face, abdominal pain, and stable vital signs, diagnosed with Varicella Zoster, and currently on medications including Acyclovir (antiviral), Omep (Omeprazole) (proton pump inhibitor) IV for gastrointestinal protection, Mucosta (mucosal protective agent) TID, Diphenhydramine (antihistamine) 50mg IV q12, Digoxin (digitalis glycoside) 0.25mg, Rivaroxaban (anticoagulant), Diosmin+hesperidin (vasoprotective agent), Fenofibrate (fibrate), and Metformin (biguanide), with lab results showing mild leukopenia, mild anemia, hypercreatinemia, elevated liver enzymes, and hypernatremia, and a Pro BNP level of 1,100?
What are examples of drospirenone-containing combined oral contraceptives (COCs) for a female patient of reproductive age with hormonal acne?
What are the differences in pharmacology, including mechanism of action, pharmacological effects, indications, contraindications, side effects, and dosage, among local anesthetics such as lidocaine, bupivacaine (Marcaine), EMLA (Eutectic Mixture of Local Anesthetics), and other agents?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.